These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

472 related articles for article (PubMed ID: 21513518)

  • 41. Plantamajoside inhibits the proliferation and epithelial-to-mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia-inducible factor-1α-dependent gene expression.
    Yin W; Xu J; Li C; Dai X; Wu T; Wen J
    Cell Biol Int; 2020 Aug; 44(8):1616-1627. PubMed ID: 32239594
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of anticancer effects of Juniperus communis extract on hepatocellular carcinoma cells in vitro and in vivo.
    Huang NC; Huang RL; Huang XF; Chang KF; Lee CJ; Hsiao CY; Lee SC; Tsai NM
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34151367
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cell division cyclin 25C knockdown inhibits hepatocellular carcinoma development by inducing endoplasmic reticulum stress.
    Li YF; Zheng FY; Miao XY; Liu HL; Zhang YY; Chao NX; Mo FR
    World J Gastroenterol; 2024 May; 30(19):2564-2574. PubMed ID: 38817663
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Midazolam inhibits proliferation and accelerates apoptosis of hepatocellular carcinoma cells by elevating microRNA-124-3p and suppressing PIM-1.
    Qi Y; Yao X; Du X
    IUBMB Life; 2020 Mar; 72(3):452-464. PubMed ID: 31651086
    [TBL] [Abstract][Full Text] [Related]  

  • 45. UNC119 promoted cell growth and migration by Wnt/β-catenin signal and TGF-β/EMT signal pathway in hepatocellular carcinoma.
    Liu ZH; Zhang YF; Xu ZD; Z H L; Y F Z; Z D X
    J BUON; 2018; 23(6):1717-1724. PubMed ID: 30610799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MicroRNA-6809-5p mediates luteolin-induced anticancer effects against hepatoma by targeting flotillin 1.
    Yang PW; Lu ZY; Pan Q; Chen TT; Feng XJ; Wang SM; Pan YC; Zhu MH; Zhang SH
    Phytomedicine; 2019 Apr; 57():18-29. PubMed ID: 30668319
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tripartite motif-containing 3 (TRIM3) inhibits tumor growth and metastasis of liver cancer.
    Huang XQ; Zhang XF; Xia JH; Chao J; Pan QZ; Zhao JJ; Zhou ZQ; Chen CL; Tang Y; Weng DS; Zhang JH; Xia JC
    Chin J Cancer; 2017 Sep; 36(1):77. PubMed ID: 28950898
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Increased expression of SLC46A3 to oppose the progression of hepatocellular carcinoma and its effect on sorafenib therapy.
    Zhao Q; Zheng B; Meng S; Xu Y; Guo J; Chen LJ; Xiao J; Zhang W; Tan ZR; Tang J; Chen L; Chen Y
    Biomed Pharmacother; 2019 Jun; 114():108864. PubMed ID: 30981107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Baicalein inhibits the invasion and metastatic capabilities of hepatocellular carcinoma cells via down-regulation of the ERK pathway.
    Chen K; Zhang S; Ji Y; Li J; An P; Ren H; Liang R; Yang J; Li Z
    PLoS One; 2013; 8(9):e72927. PubMed ID: 24039823
    [TBL] [Abstract][Full Text] [Related]  

  • 51. LncRNA SNHG7 accelerates the proliferation, migration and invasion of hepatocellular carcinoma cells via regulating miR-122-5p and RPL4.
    Yang X; Sun L; Wang L; Yao B; Mo H; Yang W
    Biomed Pharmacother; 2019 Oct; 118():109386. PubMed ID: 31545291
    [TBL] [Abstract][Full Text] [Related]  

  • 52. 1,25(OH)
    Huang J; Yang G; Huang Y; Zhang S
    Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M; Gao H; Ju P; Gao MQ; Yuan YP; Chen XH; Liu KL; Han YT; Han ZW
    Biomed Pharmacother; 2018 Jul; 103():272-283. PubMed ID: 29656183
    [TBL] [Abstract][Full Text] [Related]  

  • 54. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways.
    Di T; Luo QY; Song JT; Yan XL; Zhang L; Pan WT; Guo Y; Lu FT; Sun YT; Xia ZF; Yang LQ; Qiu MZ; Yang DJ; Sun J
    Int Immunopharmacol; 2024 Sep; 139():112615. PubMed ID: 39032475
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insufficient radiofrequency ablation promotes the metastasis of residual hepatocellular carcinoma cells via upregulating flotillin proteins.
    Zhang N; Li H; Qin C; Ma D; Zhao Y; Zhu W; Wang L
    J Cancer Res Clin Oncol; 2019 Apr; 145(4):895-907. PubMed ID: 30820716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway.
    Xie Y; Du J; Liu Z; Zhang D; Yao X; Yang Y
    J Exp Clin Cancer Res; 2019 Jan; 38(1):7. PubMed ID: 30621734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition.
    Charette N; De Saeger C; Lannoy V; Horsmans Y; Leclercq I; Stärkel P
    Mol Cancer; 2010 Sep; 9():256. PubMed ID: 20860815
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Preparation of a Novel One-Armed Anti-c-Met Antibody with Antitumor Activity Against Hepatocellular Carcinoma.
    Yin Y; Guo J; Teng F; Yu L; Jiang Y; Xie K; Jiang M; Fang J
    Drug Des Devel Ther; 2019; 13():4173-4184. PubMed ID: 31849449
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circ_0015756 promotes proliferation, invasion and migration by microRNA-7-dependent inhibition of FAK in hepatocellular carcinoma.
    Liu L; Yang X; Li NF; Lin L; Luo H
    Cell Cycle; 2019 Nov; 18(21):2939-2953. PubMed ID: 31522588
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.